Naima Hammoudi

11.8k total citations
19 papers, 560 citations indexed

About

Naima Hammoudi is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Naima Hammoudi has authored 19 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Oncology. Recurrent topics in Naima Hammoudi's work include Cancer, Hypoxia, and Metabolism (4 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Cardiac Arrhythmias and Treatments (3 papers). Naima Hammoudi is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Cardiac Arrhythmias and Treatments (3 papers). Naima Hammoudi collaborates with scholars based in United States, Algeria and France. Naima Hammoudi's co-authors include Peng Huang, Celia Garcı́a-Prieto, Kausar Begam Riaz Ahmed, Jinyun Liu, Hélène Pelicano, Rui‐Hua Xu, Wan Zhang, Lajos Pusztai, Florian L. Müller and Nikunj Satani and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and European Heart Journal.

In The Last Decade

Naima Hammoudi

18 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naima Hammoudi United States 10 336 196 115 44 41 19 560
F. C. Campos Brazil 8 187 0.6× 78 0.4× 133 1.2× 28 0.6× 35 0.9× 11 480
Yong-Min Choi South Korea 7 228 0.7× 80 0.4× 82 0.7× 18 0.4× 36 0.9× 11 479
Yu-Chu Su Taiwan 15 297 0.9× 115 0.6× 108 0.9× 28 0.6× 114 2.8× 18 605
Naoshad Mohammad India 10 412 1.2× 305 1.6× 137 1.2× 27 0.6× 82 2.0× 11 668
Xia Yuan China 14 328 1.0× 112 0.6× 253 2.2× 31 0.7× 33 0.8× 33 878
Xi Su China 12 229 0.7× 101 0.5× 78 0.7× 25 0.6× 19 0.5× 28 454
Lixia Zheng China 13 208 0.6× 81 0.4× 65 0.6× 26 0.6× 40 1.0× 30 451
Pei‐Ru Wu Taiwan 10 249 0.7× 82 0.4× 76 0.7× 34 0.8× 32 0.8× 17 473

Countries citing papers authored by Naima Hammoudi

Since Specialization
Citations

This map shows the geographic impact of Naima Hammoudi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naima Hammoudi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naima Hammoudi more than expected).

Fields of papers citing papers by Naima Hammoudi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naima Hammoudi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naima Hammoudi. The network helps show where Naima Hammoudi may publish in the future.

Co-authorship network of co-authors of Naima Hammoudi

This figure shows the co-authorship network connecting the top 25 collaborators of Naima Hammoudi. A scholar is included among the top collaborators of Naima Hammoudi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naima Hammoudi. Naima Hammoudi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yan, Victoria C., Yasaman Barekatain, Yu-Hsi Lin, et al.. (2023). Comparative Pharmacology of a Bis-Pivaloyloxymethyl Phosphonate Prodrug Inhibitor of Enolase after Oral and Parenteral Administration. ACS Pharmacology & Translational Science. 6(2). 245–252. 3 indexed citations
2.
Guedeney, Paul, Mikaël Laredo, Michel Zeitouni, et al.. (2022). Supraventricular arrhythmia following patent foramen ovale percutaneous closure. European Heart Journal. 43(Supplement_2). 1 indexed citations
3.
Hammoudi, Naima, et al.. (2020). The electrocardiographic peculiarities of Algerian competitive athletes in the region of Sétif. Archives of Cardiovascular Diseases Supplements. 12(1). 151–151.
4.
Pisaneschi, Federica, Yu-Hsi Lin, Paul G. Leonard, et al.. (2019). The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues. Molecules. 24(13). 2510–2510. 8 indexed citations
5.
Hammoudi, Naima, et al.. (2019). Preparation of active antimicrobial and antifungal alginate-montmorillonite/lemon essential oil nanocomposite films. Materials Technology. 35(7). 383–394. 35 indexed citations
6.
Fischer, Quentin, Jean‐Louis Georges, Claude Le Feuvre, et al.. (2018). Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: “OLTAT registry”. International Journal of Cardiology. 264. 64–69. 18 indexed citations
7.
Hammoudi, Naima, et al.. (2018). Economic burden of thromboembolic and hemorrhagic complications in non-valvular atrial fibrillation in Algeria (the ELRAGFA study). Journal of Medical Economics. 21(12). 1213–1220. 4 indexed citations
8.
Zaidi, Zoubida, et al.. (2017). Study of congenital heart diseases in patients with Down syndrome in Algeria. Eastern Mediterranean Health Journal. 23(9). 632–636. 5 indexed citations
9.
Leonard, Paul G., Nikunj Satani, David S. Maxwell, et al.. (2016). SF2312 is a natural phosphonate inhibitor of enolase. Nature Chemical Biology. 12(12). 1053–1058. 73 indexed citations
10.
Satani, Nikunj, et al.. (2016). ENOblock Does Not Inhibit the Activity of the Glycolytic Enzyme Enolase. PLoS ONE. 11(12). e0168739–e0168739. 22 indexed citations
11.
Ogasawara, Marcia A., Jinyun Liu, Hélène Pelicano, et al.. (2016). Alterations of mitochondrial biogenesis in chronic lymphocytic leukemia cells with loss of p53. Mitochondrion. 31. 33–39. 13 indexed citations
12.
Hammoudi, Naima, et al.. (2015). Trileaflet mitral valve associated with a bicuspid aortic valve. Journal of Cardiology Cases. 13(2). 37–39. 2 indexed citations
13.
Yuan, Shuqiang, Yun‐Xin Lu, Jing Yang, et al.. (2015). Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism. Stem Cell Research & Therapy. 6(1). 198–198. 43 indexed citations
14.
Pelicano, Hélène, Wan Zhang, Jinyun Liu, et al.. (2014). Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential. Breast Cancer Research. 16(5). 434–434. 159 indexed citations
15.
Hammoudi, Naima, et al.. (2013). Rôle du bruit dans le développement de l’hypertension artérielle en milieu aéroportuaire. Annales de Cardiologie et d Angéiologie. 62(3). 166–171. 5 indexed citations
16.
Friedrich, Felix W., Gilles Dilanian, Denise Juhr, et al.. (2012). A Novel Genetic Variant in the Transcription Factor Islet-1 Exerts Gain of Function on Myocyte Enhancer Factor 2C Promoter Activity. European Journal of Heart Failure. 15(3). 267–276. 21 indexed citations
17.
Garcı́a-Prieto, Celia, Kausar Begam Riaz Ahmed, Zhao Chen, et al.. (2012). Effective Killing of Leukemia Cells by the Natural Product OSW-1 through Disruption of Cellular Calcium Homeostasis. Journal of Biological Chemistry. 288(5). 3240–3250. 51 indexed citations
18.
Hammoudi, Naima, Kausar Begam Riaz Ahmed, Celia Garcı́a-Prieto, & Peng Huang. (2011). Metabolic alterations in cancer cells and therapeutic implications. Chinese Journal of Cancer. 30(8). 508–525. 93 indexed citations
19.
Éderhy, Stéphane, et al.. (2005). Prévention des accidents vasculaires cérébraux dans la fibrillation auriculaire non valvulaire. La Presse Médicale. 34(18). 1315–1324. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. C. Campos Breakdown of academic impact, for papers by Yong-Min Choi Breakdown of academic impact, for papers by Yu-Chu Su Breakdown of academic impact, for papers by Naoshad Mohammad Breakdown of academic impact, for papers by Xia Yuan Breakdown of academic impact, for papers by Xi Su Breakdown of academic impact, for papers by Lixia Zheng Breakdown of academic impact, for papers by Pei‐Ru Wu
Rankless by CCL
2026